![Paul Spencer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Spencer
Contatto Relazioni con gli Investitori presso TIZIANA LIFE SCIENCES LTD
Posizioni attive di Paul Spencer
Società | Posizione | Inizio | Fine |
---|---|---|---|
TIZIANA LIFE SCIENCES LTD | Contatto Relazioni con gli Investitori | 01/12/2022 | - |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Paul Spencer
Statistiche
Distribuzione geografica
Bermuda | 2 |
Regno Unito | 2 |
Posizioni
Investor Relations Contact | 2 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
TIZIANA LIFE SCIENCES LTD | Health Technology |
Aziende private | 1 |
---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Paul Spencer
- Esperienza